guaifenesin has been researched along with Parkinson Disease, Secondary in 1 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, JT | 1 |
| Liu, XY | 1 |
| Liu, JH | 1 |
| Li, GW | 1 |
| Zheng, LF | 1 |
| Zhang, XL | 1 |
| Zhang, Y | 1 |
| Feng, XY | 1 |
| Zhu, JX | 1 |
1 other study available for guaifenesin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Reduced acetylcholine and elevated muscarinic receptor 2 in duodenal mucosa contribute to the impairment of mucus secretion in 6-hydroxydopamine-induced Parkinson's disease rats.
Topics: Acetylcholine; Animals; Duodenum; Intestinal Mucosa; Male; Mucus; Oxidopamine; Parkinson Disease, Se | 2021 |